Renal failure secondary to diabetic nephropathy. Review of characteristics in diabetic patients who started hemodyalisis in Catalonia in 1994;Insuficiencia renal secundaria a nefropatía diabética. Revisión de las características de los pacientes diabéticos que iniciaron diálisis en Cataluña en 1994

Revista Clinica Espanola

Volumn 199, Issue 1, 1999, Pages 8-12

  Gonzalez Alvarez M T ^a   Castell, C ^b   Esmatjes, E ^b   Tresserras, R ^b   De Lara, N ^b   Lloveras, G ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b NONE

Author keywords

Diabetic nephropathy; Dialysis; End stage renal failure

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CONFIDENCE INTERVAL; DIABETIC NEPHROPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SPAIN; STATISTICS;

ADULT; AGED; CHRONIC DISEASE; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; QUESTIONNAIRES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SPAIN;

EID: 0039613881     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. U. S. Renal Data System, USRDS 1994. Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 1994.
2. Joint Working Party on Diabetic Renal Failure of the British Diabetes Association and Research Unit, Royal College of Physicians. Renal failure in diabetics in the United Kingdom: deficient provision of care in 1985. Diabetic Med 1986; 5:79-84.
3. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med 1985; 78:785-794.
4. Dahl-Jorgensen K, Hanssen KF, Kicnill P, Bjoro P, Sandvik L, Aegenaesi O. Reduction of urinary albumin excretion after 4 years of continous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Acta End (Copenhagen) 1988; 11(7): 19-25.
5. Amoack E, Glickman JL, Malchoff CD. Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol 1988; 8:204-211.
6. Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 1976; 36:383-388.
7. Parving HH, Andersen AR, Smidt VM, Hommel E, Mathiesen ER. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294:1.443-1.447.
8. Informe estadístic del Registre de Matalts Renals de Catalunya 1994. Generalitat de Catalunya. Servei Catalá de la Salut. Barcelona, 1995.
9. Seaqist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. New Engl J Med 1989; 320:1.161-1.165.
10. Krolewski AS, Canessa N, Warran JH, et al. Predisposition to hypertension and susceptibility to renal disease in insulin dependent diabetes mellitus. New Eng J Med 1988; 318:140-145.
11. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I diabetes. An epidemiological study. Diabetologia 1983; 25:496-501.
12. González MT. Renoprotección en el diabético mediante inhibidores de la ECA. Rev Clin Esp 1991; 189:351-352.
13. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa Ph. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297:1.092-1.095.
14. Christensen CK, Mogensen CE. Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension 1985; 7(suppl II):109-113.
15. Viberti GC, Bilous RW, Mackintosh D, Keen H. Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med 1983; 74:256.
16. Watkins PJ, Blairiey JD, Brewer DB, et al. The natural history of diabetic renal disease. Q J Med 1972; 41:437-456.
17. Rossing P, Hommel E, Smidth VM, Parving HH. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM. Diabetes 1993; 42:715.
18. Hasslacher Ch, Stech W, Wahl P, Ritz E. Natural history of nephropathy in type I diabetes. Roles of metabolic control and hypertension. Kidney Int 1984; 25:166.
19. Esmatges E, Castell C, González MT, Tresserras R, Lloveras G. The Catalan Diabetic Nephropathy study group. Epidemiology of renal involvement in type II diabetics (NIDDM) in Catalonia. Diabetes Res and Clin Practice 1996; 32:157-163.
20. Esmatges E, Castell C, Goday A, et al. Prevalencia de nefropatía en la diabetes mellitus tipo I. Med Clín 1988; 110:6-10.
21. Rodríguez JA, Cleries M, Vela E and Renal Registry Committee. Diabetic patients on renal replacement theraphy. Analysis of catalan registry data. Nephrology Dial and Transpl 1997; 12:2.501-2.509.
22. Raine AEG. Epidemiology. Development and treatment of end stage renal failure in non-insulin dependent diabetics in Europe. Diabetologia 1993; 36:1.099-1.104.
23. Marcelli D, Spotti D, Conte F, et al. Prognosis of diabetic patients on dialysis: analysis of Lombardy Registry Data. Nephrol Dial Transpl 1996; 11:393-394.
24. Lippert J, Ritz E, Schwarzbeck A, Achneider P. The rising tide of end stage renal failure from diabetic nephropathy type II and epidemiological analysis. Nephrol Dial Transp 1995; 10:462-467.
25. Robles NR, Cid MC, Pizarro JL, Sánchez-Casado E. End stage renal failure due to diabetic nephropathy in Spain. Nephrol Dial Transpl 1996; 11:393-394.
26. o 30, 1997.
27. Friedman EA. Management choices in diabetic end stage renal disease. Nephrol Dial Transpl 1995; 10 (suppl 7):61-69.
28. Markell MS, Friedman EA. Care of the diabetic patient with end stage renal disease. Semin Nephrol 1990; 10:274-286.
29. Tzamalovkas AH. Diabetes. En: Daugirdas JT, Ing TS, eds. Manual de diálisis. Barcelona: Masson-Little Brown, 1966.
30. De Fronzo RA. Hyperkaliemia and hyporeninemic hypoaldosteronism. Kidney Int 1980; 17:118-134.
31. Maiorca R, Vonesh EF, Cavalli P, et al. A multicenter selection-adjusted comparison of patient and technical survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11:118.
32. Grefberg N, Danielson BG, Nilsson P. Continous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy. Acta Med Scand 1984; 215:427.
33. Serkes KD, Blagg CD, Nolph KD. Comparison of patient and technique survival in continous ambulatory peritoneal dialysis and hemodialysis. A multicenter study. Perit Dial Int 1990; 10:15.
34. Sutherland DER. Indications for pancreas transplantation. A comentary. Clin Transpl 1990; 4:242-246.
35. Chahaz PS, Kohner EM. The relationship between diabetic retinopathy and diabetic nephropathy. Diabetic Nephropathy 1983; 2:4-6.
36. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy. Incidence and risk factors. Diabetología 1987; 30:144.
37. Kamper AL, Nielsen OJ. Effect of enalapril on hemodialysis and serum erytrophoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 1990; 50:611-618.
38. Kjellstrand CM, Goetz FC, Najarian JS. Transplantation and dialysis in diabetic patients: an update. En: Friedman EA, L'Esperance FA, eds. Diabetic renal retinal syndrome. New York: Grune & Stratton, 1980.
39. Pommer W, Bressel F, Chen F, Molzahn M. There is room for improvement of preterminal care in diabetic patients with end stage renal failure. The epidemiological evidence in Germany. Nephrol Dial Transpl 1997; 12:1.318-1.320.